MedTrace Logo

Comparative Effectiveness of Different Drugs Used to tr€at Patients in Rheumatoid Arthritis Saudi Database (RASD)"

NCT06417138 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 800

Last updated 2024-06-11

No results posted yet for this study

Summary

Comparative effectiveness of different drugs used to treat patients in Rheumatoid Arthritis Saudi database (RASD)

The goal of this observational study is to compare the effectiveness of different biological Disease Modifying Antirheumatic Drugs (bDMARDs) and targeted synthetic (tsDMARDs) using Disease Activity Score - 28 joints - C-Reactive Protien (DAS-28-CRP) and Clinical Disease Activity Index (CDAI) scores. In rheumatoid arthritis patients in Saudi Arabia who are part of Rheumatoid Arthritis Saudi Database (RASD).

The main question\[s\] it aims to answer:

* What is the most effective drug (biologocal or targeted synthetic) disease modifying antirheumatic drug used to treat rheumatoid arthritis in Saudi Arabia?
* We are going to use two outcome mesures: Disease Activity Score - 28 joints - C-Reactive Protien (DAS-28-CRP) and Clinical Disease Activity Index (CDAI) scores

Researchers will compare the treatment of rheumatoid arthritis using specific outcome measures in Rheumatoid Arthritis in Saudi Arabia.

* Participants will be enrolled after a signed written concent in our Rheumatoid Arthritis Saudi Databas (RASD).
* Their treatment data will used to compare the effectiveness of different drugs they are using.

Conditions

  • Rheumatoid Arthritis RA

Interventions

OTHER

biological and targeted synthetic disease modifying anti rheumatic drugs (bDMARDs) and (tsDMARDs)

This is a registry-based study. It is an observational, retrospective trial. There is/are no interventional drug(s).

Sponsors & Collaborators

  • Umm Al-Qura University

    lead OTHER

Principal Investigators

  • Hani Almoallim, Professor · Umm Al-Qura University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2025-02-15
Completion
2025-03-15

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06417138 on ClinicalTrials.gov